HNSBF - Hansa Biopharma GAAP EPS of -SEK1.75, revenue of SEK 30.8M
2025-10-30 08:45:01 ET
More on Hansa Biopharma
- Hansa Biopharma AB (publ) Discusses on ConfIdeS US Phase 3 Pivotal Trial Topline Results Presentation
- Hansa Biopharma AB (Publ) Discusses On ConfIdeS US Phase 3 Pivotal Trial Topline Results Call (Transcript)
- Seeking Alpha’s Quant Rating on Hansa Biopharma
- Historical earnings data for Hansa Biopharma
- Financial information for Hansa Biopharma